| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Gena Heidary | Q37830818 |
| P2093 | author name string | Deborah Vanderveen | |
| Lois E Smith | |||
| P2860 | cites work | Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor | Q73226153 |
| Essential role of growth hormone in ischemia-induced retinal neovascularization | Q73407423 | ||
| Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis | Q73640440 | ||
| Ten-year follow-up from the CRYO-ROP study | Q74305142 | ||
| A double-edged sword: erythropoietin eyed in retinopathy of prematurity | Q81038093 | ||
| Extreme Prematurity and Fibroblastic Overgrowth of Persistent Vascular Sheath Behind Each Crystalline Lens: I. Preliminary report | Q90589298 | ||
| Childhood blindness in the context of VISION 2020--the right to sight | Q28361918 | ||
| Vascular endothelial growth factor is a secreted angiogenic mitogen | Q28646475 | ||
| Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis | Q29617644 | ||
| Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: seven-year outcome | Q30994279 | ||
| Erythropoietin and VEGF exhibit equal angiogenic potential | Q33184235 | ||
| Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model | Q33347690 | ||
| Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs | Q34408269 | ||
| Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization | Q34749337 | ||
| HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin | Q34775400 | ||
| Twenty years of childhood blindness: what have we learnt? | Q34887833 | ||
| Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity | Q35108428 | ||
| Animal models of oxygen-induced retinopathy | Q35109399 | ||
| Erythropoietin as an angiogenic factor. | Q35544368 | ||
| Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis | Q35817458 | ||
| Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. | Q35897076 | ||
| Erythropoietin deficiency decreases vascular stability in mice. | Q36404124 | ||
| Vascular endothelial growth factor in eye disease | Q36929380 | ||
| Docosanoids are multifunctional regulators of neural cell integrity and fate: significance in aging and disease | Q37024930 | ||
| Docosahexaenoic acid and the aging brain | Q37152345 | ||
| Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy | Q37607034 | ||
| IGF-I is critical for normal vascularization of the human retina | Q39607676 | ||
| Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia | Q40935597 | ||
| Clinical and experimental studies on retinal neovascularization. XXXIX Edward Jackson Memorial Lecture | Q41542304 | ||
| Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia | Q41677354 | ||
| Astrocyte-endothelial cell relationships during human retinal vascular development. | Q44909673 | ||
| Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California). | Q45858766 | ||
| Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF. | Q45880105 | ||
| Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture | Q46425533 | ||
| Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity | Q47629197 | ||
| Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy | Q47908167 | ||
| Retinal Vascular Development in Premature Infants | Q67014041 | ||
| Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group | Q69916005 | ||
| Oxygen-induced retinopathy in the mouse | Q71608431 | ||
| The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis | Q72298016 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | retinopathy of prematurity | Q1423087 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 77-81 | |
| P577 | publication date | 2009-03-01 | |
| P1433 | published in | Seminars in Ophthalmology | Q7449468 |
| P1476 | title | Retinopathy of prematurity: current concepts in molecular pathogenesis | |
| P478 | volume | 24 |
| Q38773072 | A histological and immunohistochemical study of the effects of N-acetyl cysteine on retinopathy of prematurity by modifying insulin-like growth factor-1. |
| Q37082206 | A murine model for retinopathy of prematurity identifies endothelial cell proliferation as a potential mechanism for plus disease |
| Q34410734 | Analysis of candidate genes for macular telangiectasia type 2 |
| Q35176404 | Association of Maternal Age to Development and Progression of Retinopathy of Prematurity in Infants of Gestational Age under 33 Weeks |
| Q28750081 | Astrocyte-derived vascular endothelial growth factor stabilizes vessels in the developing retinal vasculature |
| Q50453482 | Bevacizumab modulates the process of fibrosis in vitro |
| Q27026663 | Beyond building better brains: bridging the docosahexaenoic acid (DHA) gap of prematurity |
| Q59326796 | Comparative Effects of Coenzyme Q10 or -3 Polyunsaturated Fatty Acid Supplementation on Retinal Angiogenesis in a Rat Model of Oxygen-Induced Retinopathy |
| Q93080964 | Defocused Image Changes Signaling of Ganglion Cells in the Mouse Retina |
| Q85204911 | Early administration of erythropoietin in the extreme premature, a risk factor for retinopathy of prematurity? |
| Q34755438 | Early nutrition and weight gain in preterm newborns and the risk of retinopathy of prematurity |
| Q41991883 | Effects of microRNA-29a on retinopathy of prematurity by targeting AGT in a mouse model |
| Q85203769 | Erythropoietin in neonates |
| Q64902724 | Exosomes from Microglia Attenuate Photoreceptor Injury and Neovascularization in an Animal Model of Retinopathy of Prematurity. |
| Q33535171 | From combinatorial peptide selection to drug prototype (I): targeting the vascular endothelial growth factor receptor pathway |
| Q36531084 | Functional analyses of TNFR2 in physiological and pathological retina angiogenesis |
| Q37807299 | How to overcome retinal neuropathy: The fight against angiogenesisrelated blindness |
| Q37694105 | Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling |
| Q47720002 | Influences of placental growth factor on mouse retinal vascular development. |
| Q82771327 | Laser treatment for retinopathy of prematurity |
| Q30418921 | Pericytes derived from adipose-derived stem cells protect against retinal vasculopathy |
| Q37627442 | Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization |
| Q35518931 | Placenta microbiology and histology and the risk for severe retinopathy of prematurity |
| Q90476018 | Prethreshold retinopathy of prematurity: VEGF inhibition without VEGF inhibitors |
| Q34805681 | Prolyl hydroxylase domain protein 2 (PHD2) mediates oxygen-induced retinopathy in neonatal mice |
| Q34335696 | Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3. |
| Q33943655 | Protective and antioxidant effects of PPARα in the ischemic retina |
| Q83396903 | Protective role of somatostatin receptor 2 against retinal degeneration in response to hypoxia |
| Q39938019 | Retinal protective effects of resveratrol via modulation of nitric oxide synthase on oxygen-induced retinopathy |
| Q90175770 | Retinopathy of Prematurity Incidence and Risk Factors in a Tertiary Hospital in Riyadh, Saudi Arabia |
| Q60439193 | Retinopathy of prematurity |
| Q68289981 | Retinopathy of prematurity |
| Q35587285 | Safety and angiogenic effects of systemic gene delivery of a modified erythropoietin |
| Q38939564 | The Nicotinic Cholinergic Pathway Contributes to Retinal Neovascularization in a Mouse Model of Retinopathy of Prematurity |
| Q57165717 | The genetics of retinopathy of prematurity: a model for neovascular retinal disease |
| Q28594681 | The vitreous glycoprotein opticin inhibits preretinal neovascularization |
| Q85748112 | Twin-twin transfusion syndrome as a possible risk factor for the development of retinopathy of prematurity |
Search more.